Clinical Trial: Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Pilot Study: Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder

Brief Summary: The purpose of this study is to investigate the clinical efficacy of Levetiracetam in the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in an open label study.

Detailed Summary:
Sponsor: Berkshire Health Systems

Current Primary Outcome: Daily Record of Severity of Problems (DRSP), Clinical Global Impression- Severity (CGI-S) and Clinical Global Impression-Improvement (CGI-I). [ Time Frame: 4 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome: How Levetiracetam is tolerated, adverse events. [ Time Frame: 4 months ]

Original Secondary Outcome: Same as current

Information By: Berkshire Health Systems

Dates:
Date Received: August 16, 2007
Date Started: November 2003
Date Completion:
Last Updated: August 17, 2007
Last Verified: August 2007